The purpose of the New Therapy - Commercialization Grants Program and Epilepsy Innovation Seal of Excellence Award is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient.
The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source.
Contact information submitted to the ERC will be used to help connect epilepsy researchers with funding organizations exclusively. Your email will not be sold or shared with organizations unrelated to this effort.
Please enter your email address below. If you are already a member you will be logged in.
If you are not a current member, you will be registered automatically.
Please enter a valid email address.Your email address has been registered. Please check your email for further instructions.
The email address you entered is associated with an existing account.